SEC Form 4 · accession 0001171843-16-009043
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen R. Mascioli
Officer — Chief Medical Officer
Period of report
Apr 4, 2016
Accepted (ET)
Apr 6, 2016 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $44.54 | Apr 4, 2016 | A | 40,000 | A | — | Apr 4, 2026 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1The stock options vest in four equal annual installments beginning April 4, 2017.